Multi-site observational study seeks to redefine the standard of care for pediatric hydrocephalus management GUILFORD, Conn.--(BUSINESS WIRE)-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking ...
AUSTIN, Texas, July 14, 2022 (GLOBE NEWSWIRE) -- Today, at HA Connect!, the 17th annual national conference on hydrocephalus, Hyperfine—creator of Swoop ®, the first FDA-cleared portable magnetic ...
A 3 year-old girl presented with an enlarging head circumference in association with headaches and an altered gait. On examination, she had papilledema, impaired upgaze, and bilateral lid retraction.
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world’s first FDA-cleared portable magnetic resonance ...